Development of PROTACs for targeted degradation of oncogenic TRK fusions
Saurav Kumar(Fred Hutch Cancer Center), Behnam Nabet(University of Washington)
Cited by 0
Related Papers
Development and Characterization of Selective FAK Inhibitors and PROTACs with <i>In Vivo</i> Activity
|ChemBioChem|2023|16
Cas phosphorylation regulates focal adhesion assembly
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0
Development of PROTACs for targeted degradation of oncogenic TRK fusions
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0